Weight Loss: In addition to managing diabetes, Mounjaro has shown significant benefits for weight loss, even in patients without diabetes
It works as both a GLP-1 agonist and a GIP receptor agonist, which helps explain why patients lose more weight compared to many older medications
This includes individuals who are lean with dyslipidemia or severely obese with cardio-renal comorbidities
SGLT2 inhibitors Empagliflozin: Empagliflozin is a novel SGLT2 inhibitor, the underlying mechanisms of which include ameliorating hyperglycemia, preventing the development of endothelial dysfunction, reducing oxidative stress, and improving metabolic profiles
This velvety-rich, intensely moisturizing night cream delivers time-released nutrition throughout the night to retexturize skin, relax the appearance of expression lines and improve skin elasticity
This timeframe applies to both unopened and opened pens, though with slightly different conditions